Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00026494).
- Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy – Observational Program (Study P04816): Complete Statistical AnalysisIndependent statistical analysis of Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Temozolomide in Treating Patients With Low-Grade Glioma: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide in Treating Patients With Low-Grade Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00313729).
- Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Temporal Interference Methods for Non-invasive Deep Brain Stimulation, Study 1.2: Complete Statistical AnalysisIndependent statistical analysis of Temporal Interference Methods for Non-invasive Deep Brain Stimulation, Study 1.2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07339072).
- Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis: Complete Statistical AnalysisIndependent statistical analysis of Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00432835).
- Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea: Complete Statistical AnalysisIndependent statistical analysis of Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01020305).
- Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B: Complete Statistical AnalysisIndependent statistical analysis of Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM): Complete Statistical AnalysisIndependent statistical analysis of Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tension Versus Tension- Free Foley Balloon for Cervical Ripening: Complete Statistical AnalysisIndependent statistical analysis of Tension Versus Tension- Free Foley Balloon for Cervical Ripening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05404776).
- TePOPIndependent statistical analysis of Telehealth Group Intervention for Perinatal Depressive Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03932760).
- Tepotinib Hepatic Impairment Trial: Complete Statistical AnalysisIndependent statistical analysis of Tepotinib Hepatic Impairment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03546608).
- Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00833664).
- Terbinafine HCl 250 mg Tablet Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Terbinafine HCl 250 mg Tablet Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00833586).
- TERIKIDSIndependent statistical analysis of Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TESIndependent statistical analysis of Electric Stimulation of the Eye to Improve Vision After Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02019927).
- TESIndependent statistical analysis of The Safety and Efficacy of Nexalin Trans-cranial Electrical Stimulation Stimulation for the Treatment of Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TESSERACTIndependent statistical analysis of Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03574038).
- Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer:…
- Testing an Arts-based Program to Reduce Nurse Stigma Towards Perinatal Substance Use: Complete Statistical AnalysisIndependent statistical analysis of Testing an Arts-based Program to Reduce Nurse Stigma Towards Perinatal Substance Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Testing an Implementation Science Tool to Increase Cervical Cancer Screening in Mombasa, Kenya: Complete Statistical AnalysisIndependent statistical analysis of Testing an Implementation Science Tool to Increase Cervical Cancer Screening in Mombasa, Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I): Complete Statistical AnalysisIndependent statistical analysis of Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers: Complete Statistical AnalysisIndependent statistical analysis of Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W): Complete Statistical AnalysisIndependent statistical analysis of Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F): Complete Statistical AnalysisIndependent statistical analysis of Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing Doxazosin to Treat Stress Mechanisms in Alcoholism: Complete Statistical AnalysisIndependent statistical analysis of Testing Doxazosin to Treat Stress Mechanisms in Alcoholism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02989493).
- Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth: Complete Statistical AnalysisIndependent statistical analysis of Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing Financial Incentive Interventions in Dyadic-Smoker Couples: Complete Statistical AnalysisIndependent statistical analysis of Testing Financial Incentive Interventions in Dyadic-Smoker Couples: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04832360).
- Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH – Subprotocol Z1K): Complete Statistical AnalysisIndependent statistical analysis of Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1): Complete Statistical AnalysisIndependent statistical analysis of Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates: Complete Statistical AnalysisIndependent statistical analysis of Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04565353).
- Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors: Complete Statistical AnalysisIndependent statistical analysis of Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03878095).
- Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH – Subprotocol Z1C): Complete Statistical AnalysisIndependent statistical analysis of Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients: Complete Statistical AnalysisIndependent statistical analysis of Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC): Complete Statistical AnalysisIndependent statistical analysis of Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC): primary endpoint results,…
- Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer,…
- Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors: Complete Statistical AnalysisIndependent statistical analysis of Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors: primary endpoint results, effect estimate with confidence interval,…
- Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial: Complete Statistical AnalysisIndependent statistical analysis of Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval,…
- Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone: Complete Statistical AnalysisIndependent statistical analysis of Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the…
- Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma: primary endpoint results, effect…
- Testing the Effectiveness of a Falls Prevention System: Complete Statistical AnalysisIndependent statistical analysis of Testing the Effectiveness of a Falls Prevention System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03678402).
- Testing the Effectiveness of Telephone-based Early Childhood Developmental Screening: Complete Statistical AnalysisIndependent statistical analysis of Testing the Effectiveness of Telephone-based Early Childhood Developmental Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02495025).
- Testing the Effects of Palbociclib and Fulvestrant or Letrozole for Patients 70 Years of Age of Older With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing the Effects of Palbociclib and Fulvestrant or Letrozole for Patients 70 Years of Age of Older With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence…
- Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…